Role of FAPI PET/MR Combined With Gadoxetate Disodium in Assessing Hepatic Malignancies

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Hepatic Malignancies

Interventions

DIAGNOSTIC_TEST

FAPI PET/MR combined with gadoxetate disodium

Patients with clinical suspected hepatic malignancies will receive the FAPI PET/MR.

Trial Locations (1)

RECRUITING

Department of Nuclear Medicine, Daping Hospital of Army Medical University, Chongqing

All Listed Sponsors

lead

Xiao Chen

OTHER